Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Zimmer Biomet Holdings's Enterprise Value is CHF20,338 Mil.
Zimmer Biomet Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was CHF1,336 Mil. Therefore, Zimmer Biomet Holdings's EV-to-OCF for today is 15.22.
The historical rank and industry rank for Zimmer Biomet Holdings's EV-to-OCF or its related term are showing as below:
XSWX:ZBH'
s EV-to-OCF Range Over the Past 10 Years
Min: 13.85 Med: 20.64 Max: 43.34
Current: 15.07
During the past 13 years, the highest EV-to-OCF of Zimmer Biomet Holdings was 43.34. The lowest was 13.85. And the median was 20.64.
XSWX:ZBH's EV-to-OCF is ranked worse than 66.94% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 7.89
vs XSWX:ZBH: 15.07
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Zimmer Biomet Holdings's PE Ratio (TTM) for today is calculated as:
Zimmer Biomet Holdings's share price for today is CHF75.50.
Zimmer Biomet Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF3.076.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Zimmer Biomet Holdings's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zimmer Biomet Holdings EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Zimmer Biomet Holdings's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Zimmer Biomet Holdings's EV-to-OCF falls into.
Zimmer Biomet Holdings's current Enterprise Value is CHF20,338 Mil.
Zimmer Biomet Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF1,336 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zimmer Biomet Holdings (XSWX:ZBH) has a EV-to-OCF of 15.22 as of Aug. 03, 2026. This is 26% below median its historical median of 20.64. Over the past decade, Zimmer Biomet Holdings' EV-to-OCF has ranged from 13.85 to 43.34. According to the industry distribution chart, Zimmer Biomet Holdings ranks #571 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 66.9%.
Is Zimmer Biomet Holdings' EV-to-OCF too high?
Zimmer Biomet Holdings' current EV-to-OCF of 15.22 is 26% below median its 10-year median of 20.64. Over the past 10 years, this metric has ranged from a low of 13.85 to a high of 43.34. The Medical Devices & Instruments industry median EV-to-OCF is 7.89. Zimmer Biomet Holdings' value of 15.22 is 92.9% above this industry median. Based on the distribution chart, Zimmer Biomet Holdings ranks #571 out of 853 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Zimmer Biomet Holdings has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does Zimmer Biomet Holdings' EV-to-OCF compare to STE and PEN?
According to the Medical Devices & Instruments industry distribution chart, Zimmer Biomet Holdings ranks #571 out of 853 companies for EV-to-OCF. This places Zimmer Biomet Holdings in the lower half of its industry. The industry median EV-to-OCF is 7.89. Zimmer Biomet Holdings' value of 15.22 is 92.9% above this benchmark. Historically, Zimmer Biomet Holdings' own EV-to-OCF has ranged from 13.85 to 43.34 over the past decade. While the company's 10-year median is 20.64 vs. the industry median of 7.89, Zimmer Biomet Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.89, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zimmer Biomet Holdings's current EV-to-OCF of 15.22 is 92.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zimmer Biomet Holdings's current EV-to-OCF is 15.22, which is 26% below median its own 10-year median of 20.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zimmer Biomet Holdings stock overvalued right now?
Zimmer Biomet Holdings (XSWX:ZBH) has a current EV-to-OCF of 15.22. The stock's GF Value™ is CHF101.70, compared to a current price of CHF75.50 — trading 25.8% below its estimated fair value. The current EV-to-OCF is 15.22, which is 26% below median its 10-year median of 20.64 and 92.9% above the Medical Devices & Instruments industry median of 7.89. Zimmer Biomet Holdings' overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Zimmer Biomet Holdings (XSWX:ZBH), the current EV-to-OCF is 15.22 as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zimmer Biomet Holdings (XSWX:ZBH) Overvalued in 2026?
Based on GuruFocus' analysis, Zimmer Biomet Holdings stock appears to be undervalued.
The current stock price of CHF75.50 is trading 25.8% below its estimated GF Value™ of CHF101.70.
Key valuation signals for XSWX:ZBH:
EV-to-OCF: 15.22 (26% below median its 10-year median of 20.64)
GF Value™: CHF101.70 vs. price of CHF75.50 (25.8% below fair value)
Industry Position: 92.9% above the Medical Devices & Instruments median (#571 of 853)
No single metric tells the full story. See the XSWX:ZBH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
76GF Score
Get the complete analysis for XSWX:ZBH
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:ZBH has been successfully added to your 
